Previously, Oyama et al (8) reported a 64% sensitivity of FDG PET-CT in detecting primary prostate cancer; however, the subjects in the study exhibited high serum PSA levels (mean PSA level, 251 ng/ml), as well as advanced stage and aggressive cancer. The gene discussed is KLK3; the disease is cancer.